Approval of Modification of draft Scheme of Amalgamation submitted on November 12, 2025 between Hatri Pharma Private Limited (Transferor Company) and Venmax Drugs and Pharmaceuticals Limited (Transferee Company)
Board Meeting Outcome for Modification Of Draft Scheme Of Amalgamation
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 26 2026
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 23 2026
- Announcement under Regulation 30 (LODR)-Allotment
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Feb 09 2026
Later from Venmax Drugs & Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Change in Management
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 30 2026
- Regulation 31(4) - SAST Disclosure
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 06 2026
- Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals